NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Norris SL, Carson S, Thakurta S, et al. Drug Class Review: Thiazolidinediones: Final Report Update 1 [Internet]. Portland (OR): Oregon Health & Science University; 2008 Aug.
This publication is provided for historical reference only and the information may be out of date.
Evidence Table 1. Systematic reviews of TZDs
Evidence Table 2. Quality assessment of systematic reviews of TZDS
Evidence Table 3. Head-to-head trials of pioglitazone vs rosiglitazone (New for Update #1)
Evidence Table 4. Quality assessment of randomized controlled trials (New for Update 1)
Evidence Table 5. Placebo-controlled trials of pioglitazone (new for Update #1)
Evidence Table 5. Efficacy - Placebo-controlled trials type 2 diabetes, pioglitazone
Aronoff S 2000 Quality rating: Poor
Dormandy JA 2005 Quality rating: Good
Herz, M 2003 Quality rating: Fair
Kipnes, M 2001 Quality rating: Fair
Mattoo, V 2005 Quality rating: Fair
McMahon, G. 2005 Quality rating: Poor
Miyazaki, Y 2002 Quality rating: Fair
Miyazaki, Y. 2001; Miyazaki, Y. 2004 Quality rating: Poor
Negro R 2004 Quality rating: Poor
Rosenblatt, S. 2001 Quality rating: Fair
Rosenstock, J. 2002 Quality rating: Fair
Satoh N 2003 Quality rating: Poor
Scherbaum, W. 2002 Quality rating: Poor
Smith, S. 2004; Bogacka, I. 2004 Quality rating: Poor
Evidence Table 6
Evidence Table 6. Placebo-controlled trials of rosiglitazone (New for Update 1)
Evidence Table 6. Efficacy - Placebo-controlled trials, type 2 diabetes, rosiglitazone
Agrawal, A 2003 Quality rating: Fair, based on 2' data
Barnett, A 2003 Quality rating: Fair
Fonseca V 2000 Quality rating: Fair
Gomez-Perez F., 2002 Quality rating: Fair
Honisett, S 2003 Quality rating: Poor
Jones, T 2003 Quality rating: Fair
Kim, Y 2005 Quality rating: Fair
Lebovitz, H, 2001 Quality rating: Poor
Miyazaki, Y 2001 Quality rating: Fair
Nolan, J 2000 Quality rating: Fair
Patel, J 1999 Quality rating: Fair
Phillips, S 2001 Quality rating: Fair
Raskin, P, 2000 Quality rating: Fair
Raskin, P, 2001 Quality rating: Good
Reynolds L 2002 Quality rating: Poor
Tan G, 2005a Quality rating: Fair
van Wijk, J 2005 Quality rating: Fair
Wang G., 2005 Quality rating: Fair
Wolfenbuttel B., 2000 Quality rating: Fair
Evidence Table 7
Evidence Table 7. Active control trials of pioglitazone (New for Update 1)
Evidence Table 7. Efficacy - Selected active-controlled trials type 2 diabetes, pioglitazone
Belcher 2004, Khan 2004 Quality rating: NA (4 trials combined)
Charbonnel BH 2004 Quality rating: Poor
Hanefeld, M 2004 Quality rating: Fair
Matthews DR 2005 Quality rating: Fair
Saad MF 2004 Quality rating: Fair
Schernthaner G 2005 Quality rating: Fair
Evidence Table 8
Evidence Table 8. Active control trials of rosiglitazone (New for Update #1)
Evidence Table 8. Efficacy - Selected active-controlled trials type 2 diabetes, rosiglitazone
Hallsten, K 2002 Quality rating: Fair
Iozzo, P 2003 Quality rating: Fair
Natali, A 2004 Quality rating: Fair
Evidence Table 9. Efficacy - Placebo-controlled trials in prediabetes or metabolic syndrome, rosiglitazone
Bennett, S, 2004 Quality rating: Fair
Evidence Table 10. Efficacy - Active-controlled trials in prediabetes or metabolic syndrome, pioglitazone
Evidence Table 11
Evidence Table 11. Quality assessment of adverse events in efficacy trials
Evidence Table 12. Adverse events efficacy trials, pioglitazone
Evidence Table 13
Evidence Table 13. Adverse events reported in trials of rosiglitazone (New for Update 1)
Evidence Table 13. Adverse events efficacy trials, rosiglitazone
Evidence Table 14
Evidence Table 16. Adverse events in comparative observational studies of TZDs vs other agents
Evidence Table 17. Quality assessment of observational studies of adverse events
Evidence Table 18. Adverse events in observational studies and excluded trials, PIO
Evidence Table 19. Adverse events in observational studies, ROSI
- Evidence Table 5. Efficacy - Placebo-controlled trials type 2 diabetes, pioglitazone
- Evidence Table 6
- Evidence Table 7
- Evidence Table 8
- Evidence Table 9. Efficacy - Placebo-controlled trials in prediabetes or metabolic syndrome, rosiglitazone
- Evidence Table 10. Efficacy - Active-controlled trials in prediabetes or metabolic syndrome, pioglitazone
- Evidence Table 11
- Evidence Table 13
- Evidence Table 14
- Evidence Tables - Drug Class Review: ThiazolidinedionesEvidence Tables - Drug Class Review: Thiazolidinediones
Your browsing activity is empty.
Activity recording is turned off.
See more...